Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Bi-Est is a compounded hormone therapy formulation containing a combination of estradiol and estriol. The "20/80" and "50/50" designations refer to the relative proportion of the two estrogen components in the compounded formulation.
Depending on the prescribed formulation, Bi-Est may be prepared as a topical cream, rapid-dissolve tablet, capsule, or troche. A healthcare professional should determine the appropriate formulation and strength based on the patient's symptoms, medical history, treatment goals, and clinical evaluation.
Hormone therapy may be prescribed for appropriate patients to help manage certain menopausal symptoms, such as hot flashes, night sweats, and vaginal symptoms. FDA-approved hormone therapies are available in several formulations, and FDA recommends discussing the benefits and risks of hormone therapy with a healthcare professional.
Bi-Est is a compounded hormone therapy formulation containing a combination of estradiol and estriol. The "20/80" and "50/50" designations refer to the relative proportion of the two estrogen components in the compounded formulation.
Depending on the prescribed formulation, Bi-Est may be prepared as a topical cream, rapid-dissolve tablet, capsule, or troche. A healthcare professional should determine the appropriate formulation and strength based on the patient's symptoms, medical history, treatment goals, and clinical evaluation.
Hormone therapy may be prescribed for appropriate patients to help manage certain menopausal symptoms, such as hot flashes, night sweats, and vaginal symptoms. FDA-approved hormone therapies are available in several formulations, and FDA recommends discussing the benefits and risks of hormone therapy with a healthcare professional.